Medical progress: Anemia of chronic disease

被引:2322
作者
Weiss, G
Goodnough, LT
机构
[1] Med Univ Innsbruck, Dept Gen Internal Med Clin Immunol & Infect Dis, A-6020 Innsbruck, Austria
[2] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Med, Stanford, CA 94305 USA
关键词
D O I
10.1056/NEJMra041809
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1011 / 1023
页数:13
相关论文
共 102 条
  • [1] Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression
    Acs, G
    Zhang, PJ
    McGrath, CM
    Acs, P
    McBroom, J
    Mohyeldin, A
    Liu, SZ
    Lu, HS
    Verma, A
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (06) : 1789 - 1806
  • [2] Acs G, 2001, CANCER RES, V61, P3561
  • [3] Erythropoietin for end-stage renal disease
    Adamson, JW
    Eschbach, JW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) : 625 - 627
  • [4] Aguilera Abelardo, 2002, Adv Perit Dial, V18, P200
  • [5] ALVAREZHERNANDEZ X, 1989, LAB INVEST, V61, P319
  • [6] The iron transporter DMT1
    Andrews, NC
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1999, 31 (10) : 991 - 994
  • [7] Anemia of inflammation: the cytokine-hepcidin link
    Andrews, NC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (09) : 1251 - 1253
  • [8] [Anonymous], 2001, Am J Kidney Dis, V37, pS182
  • [9] Functional significance of erythropoietin receptor expression in breast cancer
    Arcasoy, MO
    Amin, K
    Karayal, AF
    Chou, SC
    Raleigh, JA
    Varia, MA
    Haroon, ZA
    [J]. LABORATORY INVESTIGATION, 2002, 82 (07) : 911 - 918
  • [10] Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial
    Auerbach, M
    Ballard, H
    Trout, JR
    McIlwain, M
    Ackerman, A
    Bahrain, H
    Balan, S
    Barker, L
    Rana, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) : 1301 - 1307